Q32 Bio Inc. (QTTB) Non-Current Debt (2023 - 2026)

Q32 Bio has reported Non-Current Debt for 4 years, with the latest figure at $1.9 million in Q1 2026.

• On a quarterly basis, Non-Current Debt fell 75.88% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 75.88% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 63.66% from the prior year.
• Non-Current Debt was $1.9 million for Q1 2026 at Q32 Bio, down from $3.5 million in the prior quarter.
• The five-year high for Non-Current Debt was $12.6 million in Q2 2024, with the low at $1.9 million in Q1 2026.
• Average Non-Current Debt over 4 years is $7.2 million, with a median of $7.3 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2026: Non-Current Debt surged 108.6% in 2024, then slumped 75.88% in 2026.
• Over 4 years, Non-Current Debt stood at $4.6 million in 2023, then soared by 108.6% to $9.6 million in 2024, then tumbled by 63.66% to $3.5 million in 2025, then slumped by 44.17% to $1.9 million in 2026.
• The last three Non-Current Debt figures came in at $1.9 million (Q1 2026), $3.5 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.